Starpharma Holdings Limited
SPHRF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $44,371 | $41,674 | $131,177 | $282,890 |
| - Cash | $15,407 | $23,360 | $35,180 | $49,918 |
| + Debt | $2,402 | $3,528 | $8,272 | $8,189 |
| Enterprise Value | $31,366 | $21,842 | $104,269 | $241,161 |
| Revenue | $4,912 | $8,289 | $4,343 | $5,162 |
| % Growth | -40.7% | 90.9% | -15.9% | – |
| Gross Profit | $3,688 | $7,657 | $1,223 | $1,906 |
| % Margin | 75.1% | 92.4% | 28.1% | 36.9% |
| EBITDA | -$10,928 | -$9,632 | -$17,042 | -$16,634 |
| % Margin | -222.5% | -116.2% | -392.4% | -322.2% |
| Net Income | -$9,990 | -$8,165 | -$15,638 | -$16,154 |
| % Margin | -203.4% | -98.5% | -360.1% | -312.9% |
| EPS Diluted | -0.024 | -0.02 | -0.038 | -0.04 |
| % Growth | -20.7% | 48.2% | 3.8% | – |
| Operating Cash Flow | -$6,759 | -$6,977 | -$13,533 | -$13,162 |
| Capital Expenditures | -$42 | -$89 | -$621 | -$837 |
| Free Cash Flow | -$6,801 | -$7,066 | -$14,154 | -$13,999 |